CINECA IRIS Institutional Research Information System

BOMBARDIERI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 43.916
AS - Asia 20.603
EU - Europa 13.481
SA - Sud America 2.631
AF - Africa 756
Continente sconosciuto - Info sul continente non disponibili 743
OC - Oceania 64
Totale 82.194
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 42.530
CN - Cina 6.301
SG - Singapore 6.243
IT - Italia 3.527
HK - Hong Kong 3.364
BR - Brasile 2.228
SE - Svezia 2.037
BG - Bulgaria 1.527
VN - Vietnam 1.484
DE - Germania 1.355
CA - Canada 1.128
TR - Turchia 1.077
UA - Ucraina 907
GB - Regno Unito 886
FI - Finlandia 814
FR - Francia 717
KR - Corea 704
RU - Federazione Russa 658
CH - Svizzera 380
IN - India 363
JP - Giappone 285
CI - Costa d'Avorio 177
AR - Argentina 138
NG - Nigeria 128
AT - Austria 123
BE - Belgio 122
BD - Bangladesh 119
SN - Senegal 118
MX - Messico 117
IQ - Iraq 95
NL - Olanda 94
ID - Indonesia 71
EG - Egitto 70
ES - Italia 69
CO - Colombia 67
ZA - Sudafrica 66
MA - Marocco 63
SA - Arabia Saudita 59
IL - Israele 53
EC - Ecuador 51
AU - Australia 50
PK - Pakistan 47
UZ - Uzbekistan 46
PL - Polonia 45
VE - Venezuela 44
KE - Kenya 34
PT - Portogallo 34
IR - Iran 30
CL - Cile 29
JO - Giordania 29
IE - Irlanda 28
CR - Costa Rica 26
PY - Paraguay 26
TN - Tunisia 26
JM - Giamaica 25
MY - Malesia 24
NP - Nepal 24
PE - Perù 23
BJ - Benin 22
GR - Grecia 22
HU - Ungheria 22
PH - Filippine 22
LT - Lituania 18
TW - Taiwan 18
AE - Emirati Arabi Uniti 17
RO - Romania 16
UY - Uruguay 16
DZ - Algeria 14
KZ - Kazakistan 14
NZ - Nuova Zelanda 14
TH - Thailandia 14
AL - Albania 13
AZ - Azerbaigian 13
CZ - Repubblica Ceca 13
EU - Europa 13
HN - Honduras 13
TT - Trinidad e Tobago 12
OM - Oman 11
PA - Panama 11
PS - Palestinian Territory 10
RS - Serbia 10
DO - Repubblica Dominicana 9
KG - Kirghizistan 9
BB - Barbados 8
BH - Bahrain 8
GT - Guatemala 8
LB - Libano 8
NO - Norvegia 8
DK - Danimarca 7
GH - Ghana 7
NI - Nicaragua 7
AM - Armenia 6
BO - Bolivia 6
BY - Bielorussia 6
ET - Etiopia 6
SK - Slovacchia (Repubblica Slovacca) 6
CG - Congo 5
KW - Kuwait 5
LK - Sri Lanka 5
MN - Mongolia 5
Totale 81.382
Salva come PNG Salva come JPEG
Città #
Woodbridge 4.445
Ashburn 4.050
Singapore 3.562
Hong Kong 3.330
Ann Arbor 3.233
Fairfield 2.954
Chandler 2.907
Houston 2.623
Santa Clara 1.870
San Jose 1.856
Dallas 1.612
Sofia 1.525
Shanghai 1.354
Seattle 1.258
Milan 1.227
Beijing 1.208
Jacksonville 1.175
Wilmington 1.121
Cambridge 1.029
New York 982
Ottawa 943
Hefei 932
Council Bluffs 925
Boardman 700
Seoul 675
Izmir 671
Princeton 636
Nanjing 603
Medford 573
Lawrence 571
Lauterbourg 509
Los Angeles 469
Des Moines 405
Bern 360
Ho Chi Minh City 335
Dearborn 283
Istanbul 278
Buffalo 256
Dong Ket 253
Tokyo 243
Hanoi 231
Nanchang 214
Jüchen 206
Bremen 201
São Paulo 194
The Dalles 191
Columbus 185
Serra 179
Abidjan 177
Florence 169
Redondo Beach 164
Helsinki 163
San Diego 160
Frankfurt am Main 141
London 138
Kunming 135
Boulder 130
Redwood City 127
Lancaster 125
Rome 125
Lagos 123
Falls Church 122
Munich 120
Dakar 116
Pune 111
Ogden 108
Vienna 105
Shenyang 104
Hebei 96
Brussels 94
Changsha 84
Chicago 84
Tianjin 80
Jiaxing 68
Norwalk 65
Phoenix 61
Rio de Janeiro 60
Brooklyn 57
Nuremberg 54
Auburn Hills 52
Hangzhou 52
Fuzhou 51
Brasília 50
Jinan 50
Montreal 50
Orange 46
San Francisco 46
Turku 46
Belo Horizonte 45
Atlanta 44
Tashkent 40
Toronto 39
Washington 39
Da Nang 38
Baghdad 37
Curitiba 37
Marseille 37
Düsseldorf 36
Detroit 35
Verona 35
Totale 59.913
Salva come PNG Salva come JPEG
Nome #
European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group 918
Antibodies against hepatitis C virus in mixed cryoglobulinemia patients. 336
Sleep disorders and systemic lupus erythematosus 278
T cell immunoregulation in rheumatoid synovitis. 260
Primary Sjogren's Syndrome: clinical and serological feature of a single centre [Sindrome di Sjogren primitiva: Descrizione clinica e sierologica di una casistica monocentrica] 258
VALUTAZIONE DELL’ASTENIA IN PAZIENTI AFFETTI DA SPONDILOARTRITE 248
Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. 239
Skin manifestations and sjögren’s syndrome 237
Correspondence between salivary proteomic pattern and clinical course in primary Sjogren syndrome and non-Hodgkin's lymphoma: a case report 232
Depression and systemic lupus erythematosus: a systematic review 230
[Ultrasound lung comets: new echographic sign of lung interstitial fibrosis in systemic sclerosis] 227
Oral sildenafil in skin ulcers secondary to systemic sclerosis. 216
The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs. 214
Low-antigen-content diet in the treatment of patients with mixed cryoglobulinemia. 214
Incident Comorbidity Among Patients with Rheumatoid Arthritis Treated or Not with Low-dose Glucocorticoids: A Retrospective Study 206
Impact of joint involvement on patients reported outcomes in systemic lupus erythematosus 206
EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome. 204
Comment on: Disease Activity Criteria in Scleroderma 203
Antinflammatory therapy and cardiovascular risk: a consensus view 201
Classification criteria 200
Fibromyalgia features in patients with primary Sjögren's syndrome. Evidence of a relationship with psychological depression. 199
Antipolymer antibody in Italian fibromyalgic patients 199
Patient preferences in the choice of anti-TNF therapies in rheumatoid arthritis. Results from a questionnaire survey (RIVIERA study) 199
Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda. 198
Abetimus sodium for renal flare in systemic lupus erythematosus: results of a randomized, controlled phase III trial 197
Association between polyarteritis and Australia antigen. 196
A proposal of simple calculation (ERI calculator) to predict the early response to TNF-a blockers therapy in rheumatoid arthritis 196
A unified list of acronyms for the rheumatology literature. 194
A model of anti-angiogenesis: differential transcriptosome profiling of microvascular endothelial cells from diffuse systemic sclerosis patients 194
Modulation of the angiogenic phenotype of normal and systemic sclerosis endothelial cells by gain-loss of function of pentraxin 3 and matrix metalloproteinase 12 194
The promising role of lung Ultrasound in Systemic Sclerosis 194
Hepatitis C virus, autoimmune liver disease and cryoglobulinaemic hepatitis. 193
Minor salivary gland biopsy and Sjögren's syndrome: comparative analysis of biopsies among different Italian rheumatologic centers. 193
MALDI-TOF and SELDI-TOF analysis: "tandem" techniques to identify potential biomarker in fibromyalgia. [MALDI-TOF e SELDI-TOF: due tecniche “tandem” per l’individuazione di potenziali biomarker nella fibromialgia] 193
A method for retracing the putative antigen/antibody ratio of immune complexes in biological fluids. 192
TNF-alpha inhibitors in Systemic Lupus Erythematosus. A case report and a systematic literature review 190
Comparison of masticatory dysfunction in temporomandibular disorders and fibromyalgia 189
Xerosis in primary Sjogren syndrome; immunohistochemical and functional investigations 188
Diagnosis and referral of rheumatoid arthritis by primary care physician: results of a pilot study on the city of Pisa, Italy 188
Autoantibodies directed against ribosomal P proteins: use of a multiple antigen peptide as the coating agent in ELISA. 187
A Clinical Prediction Rule for Lymphoma Development in Primary Sjogren's Syndrome 186
Activity criteria in systemic lupus erythematosus 185
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints. 185
Genetic polymorphisms of thiopurine S-methyltransferase in a cohort of patients with systemic autoimmune diseases 185
Subthreshold mood symptoms in patients with fibromyalgia and rheumatoid arthritis. 185
miRNA-mediated regulation of Mucin-type O-Glycosylation pathway: a putative mechanism of salivary gland dysfunction in Sjögren's syndrome 185
[Churg-Strauss vasculitis and idiopathic hypereosinophyl syndrome: role of molecular biology in the differential diagnosis of hypereosinophyl syndrome] 184
HLA antigens in Italian patients with primary Sjögren's syndrome. 183
Ultrasound imaging for the rheumatologist X. Ultrasound imaging in crystal-related arthropathies 183
Intestinal pseudo-obstruction in inactive systemic lupus erythematosus: An unusual finding 183
Skin manifestations and cryoglobulinemia 183
Adverse events during longterm low-dose glucocorticoid treatment of polymyalgia rheumatica: a retrospective study. 182
Hepatitis C virus infection in non-Hodgkin's B-cell lymphoma complicating mixed cryoglobulinaemia. 181
ARTHRITIS IN SYSTEMIC LUPUS ERYTHEMATOSUS: AN IMAGING POINT OF VIEW 181
A multidisciplinary approach to study the effects of balneotherapy and mud-bath therapy treatments on fibromyalgia. 181
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database 180
Misdiagnosis in fibromyalgia: a multicentre study 180
Occurrence of hashimoto thyroiditis among the first- and second-degree relatives of systemic lupus erythematosus patients with Hashimoto thyroiditis 180
Lung function abnormalities in different connective tissue diseases. 179
A first study of cytokine genomic polymorphisms in CFS: positive association of TNF-857 and IFNgamma 874 rare alleles 178
Minor salivary gland biopsy and Sjögren's syndrome: comparative analysis of biopsies among different Italian rheumatologic centers 178
Blunted increase of digital skin vasomotion following acetylcholine and sodium nitroprusside iontophoresis in systemic sclerosis patients 178
A SIMPLE METHOD FOR THE BIOCHEMICAL PURIFICATION OF RO/SS-A ANTIGEN 178
[Fibronectin gene polymorphisms and clinical manifestations of mixed cryoglobulinemic syndrome: increased risk of lymphoma associated to MspI DD and HaeIII AA genotypes] 177
Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study 177
Pregnant patient with dermatomyositis successfully treated with intravenous immunoglobulin therapy 177
A plasma cell granuloma in a patient with Sjögren's syndrome. 176
Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus. 176
Hyperviscosity syndrome in cryoglobulinemia: clinical aspects and therapeutic considerations. 176
Efficacy and safety of rituximab in HCV-related mixed cryoglobulinemia 176
Proteomic analysis of the saliva: a clue for understanding primary from secondary Sjögren's syndrome? 176
Anti-Sm and anti-RNP antibodies 176
Behçet's disease: features of neurological involvement in a dedicated centre in Italy. 176
The role of imaging in the evaluation of joint involvement in 102 consecutive patients with systemic lupus erythematosus 176
[Renal tubular acidosis in essential mixed cryoglobulinemia]. 174
Lung function in essential mixed cryoglobulinemia: a short-term follow-up. 174
Treatment of the renal involvement in mixed cryoglobulinemia with prolonged plasma exchange 174
In vivo confocal scanning laser microscopy in patients with primary Sjögren's syndrome: A monocentric experience. 174
Long-term griseofulvin treatment for progressive systemic sclerosis. 173
Biomarkers for Sjögren's syndrome 173
Mixed cryoglobulinemia and mortality: a review of the literature 172
A European multicenter randomized double-blind placebo-controlled monotherapy clinical trial of milnacipran in treatment of fibromyalgia 172
The interferon regulatory factor 5 gene confers susceptibility to rheumatoid arthritis and influences its erosive phenotype 172
Preliminary classification criteria for the cryoglobulinaemic vasculitis. 172
Fibromialgia, fattori neurotrofici e disturbi dell’umore 172
Undifferentiated connective tissue diseases (UCTD) 172
Epidemiology and Management of Neuropsychiatric Disorders in Behçet's Syndrome. 172
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet’s syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trial 172
A technique for immunoassay of human IgG. 171
Lung involvement in Sjögren's syndrome: a comparison between patients with primary and with secondary syndrome. 171
A case of adult periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome associated with endocapillary proliferative glomerulonephritis 171
Quantitative evaluation of 99mTc-pyrophosphate muscle uptake in patients with inflammatory and noninflammatory muscle diseases. 170
Alteration of peripheral benzodiazepine receptor density and of calcium, magnesium, ATP levels in fibromyalgia. 170
Alteration of serotonin transporter density and activity in fibromyalgia. 170
Predictors of renal outcome in diffuse proliferative glomerulonephritis in systemic lupus erythematosus 170
US Examination of Wrists and Hands: a Comparison Between Rheumatoid Arthritis and Psoriatic Arthritis 169
The targets of nephritogenic antibodies in systemic autoimmune disorders 169
Absence of xenotropic murine leukemia virus-related virus in italian patients affected by chronic fatigue syndrome, fibromyalgia, or rheumatoid arthritis 169
Slow-releasing nicardipine in the treatment of Raynaud's phenomena without underlying diseases. 168
Classification criteria for Sjogren's syndrome: A critical review. 168
Totale 19.776
Salva come PNG Salva come JPEG
Categoria #
all - tutte 230.297
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 230.297
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.927 0 444 74 428 1.177 829 150 327 312 137 278 1.771
2022/20237.483 884 872 415 877 1.021 1.076 52 597 1.149 37 431 72
2023/20245.416 911 608 727 316 774 960 103 158 116 89 123 531
2024/202516.131 37 683 112 953 1.383 1.424 1.517 1.002 1.768 2.304 2.010 2.938
2025/202615.730 1.030 2.443 1.953 956 1.544 1.620 2.835 641 770 1.144 494 300
2026/20272.187 461 1.726 0 0 0 0 0 0 0 0 0 0
Totale 82.194